Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
39.9M
-
Shares change
-
+653K
-
Total reported value, excl. options
-
$1.29B
-
Value change
-
+$17.8M
-
Put/Call ratio
-
1.03
-
Number of buys
-
86
-
Number of sells
-
-87
-
Price
-
$32.30
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2016
228 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2016.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.9M shares
of 44.9M outstanding shares and own 89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.75M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.58M shares), BlackRock Fund Advisors (1.92M shares), FMR LLC (1.75M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (1.6M shares), HealthCor Management, L.P. (1.58M shares), GILDER GAGNON HOWE & CO LLC (1.23M shares), DARUMA CAPITAL MANAGEMENT LLC (1.22M shares), Partner Fund Management, L.P. (1.16M shares), and Clearbridge Investments, LLC (1.09M shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.